Cargando…
Management of antithrombotic therapy during cardiac implantable device surgery
Anticoagulants are commonly used drugs that are frequently encountered during device placement. Deciding when to halt or continue the use of anticoagulants is a balance between the risks of thromboembolism versus bleeding. Patients taking warfarin with a high risk of thromboembolism should continue...
Autores principales: | AlTurki, Ahmed, Proietti, Riccardo, Birnie, David H., Essebag, Vidal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913137/ https://www.ncbi.nlm.nih.gov/pubmed/27354859 http://dx.doi.org/10.1016/j.joa.2015.12.003 |
Ejemplares similares
-
Catheter ablation for atrial fibrillation in heart failure with reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials
por: AlTurki, Ahmed, et al.
Publicado: (2019) -
Subclinical Atrial Fibrillation and Risk of Stroke: Past, Present and Future
por: AlTurki, Ahmed, et al.
Publicado: (2019) -
Left atrial appendage isolation in atrial fibrillation catheter ablation: A meta‐analysis
por: AlTurki, Ahmed, et al.
Publicado: (2018) -
Risk factors associated with bleeding after multi antithrombotic therapy during implantation of cardiac implantable electronic devices
por: Ishibashi, Kohei, et al.
Publicado: (2016) -
Optimization of Chronic Cardiac Resynchronization Therapy Using Fusion Pacing Algorithm Improves Echocardiographic Response
por: AlTurki, Ahmed, et al.
Publicado: (2020)